MedPath

Growth of Infants Fed an Elemental Medical Food

Phase 3
Completed
Conditions
Healthy Infants
Registration Number
NCT01699386
Lead Sponsor
Abbott Nutrition
Brief Summary

Effects on weight will be monitored in healthy infant subjects consuming assigned infant formulas.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
213
Inclusion Criteria
  • Singleton, healthy infant
  • Gestational age of 37 to 42 weeks
  • Birth weight of 2500 grams or greater
  • Age between birth and 9 days of age
  • Parents agree to not administer mineral or vitamin supplements during the study period
  • Parents agree to feed study formula exclusively for the duration of the study
Exclusion Criteria
  • Maternal, fetal or perinatal history which may have adverse effects on growth
  • Multiple birth

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Weight14 days of age to 112 days of age

weight gain during the study period

Secondary Outcome Measures
NameTimeMethod
Lab MeasurementAt 112 day visit

serum albumin

Anthropometric Measurements14 days of age to 112 days of age

length, head circumference, and length gain

GI ToleranceAt visits 14 and 28

daily stool number, stool consistency, formula intake

Trial Locations

Locations (2)

T&W Research

🇺🇸

Little Rock, Arkansas, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

T&W Research
🇺🇸Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.